Collectively, these results provide additional support for the idea that suppressing β-cell apoptosis and preserving β-cell mass by disrupting THADA function can afford significant improvements in glycemic control and protect against development of T2DM. This evidence concerns the gene THADA and type 2 diabetes mellitus.